medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 6

<< Back Next >>

Med Int Mex 2020; 36 (6)

Leser-Trélat sign associated to gastric adenocarcinoma

González-Cázares A, Carrasco-De la Vega JA, Arenas-Guzmán R

Language: Spanish
References: 24
Page: 881-887
PDF size: 224.06 Kb.


ABSTRACT

Background: Gastric cancer has been reported as one of the leading causes of overall cancer mortality around the world. Leser-Trélat’s sign is associated mostly with gastrointestinal tumors and approximately 50% of these are known to be gastric adenocarcinoma. This sign is an early clinical manifestation, which would be useful for early diagnosis.
Clinical case: A 76-year-old man with diagnosis of gastric adenocarcinoma associated to the sign of Leser-Trélat.
Conclusions: It is vitally important to recognize signs such as Leser-Trélat, because in addition to providing a broader range of diagnostic suspicion, it opens a window of time for the patients to receive the best treatment, offering them a greater chance of successful cure


REFERENCES

  1. Stawczyk-Macieja M, Szczerkowska-Dobosz A, Nowicki R, Majewska H, Dubowik M, Sokołowska-Wojdyło M. Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol 2014; 31 (1): 56-58. doi: 10.5114/pdia.2014.40663

  2. Stollmeier A, Rosario B, Mayer B, Frandoloso G, Magalhães F, Marques G. Seborrheic keratoses as the first sign of bladder carcinoma: case report of Leser-Trélat sign in a rare association with urinary tract cancer. Hindawi Publishing Corporation 2016; 2016 (425919): 1-4. doi: 10.1155/2016/4259190

  3. Colvin H, Yamamoto K, Wada N, Mori M. Hereditary gastric cancer syndromes. Surg Oncol Clin N Am 2015; 24 (4): 765- 77. doi: 10.1016/j.soc.2015.06.00

  4. El Abiad R, Gerke H. Gastric cancer: Endoscopic diagnosis and standing. Sur Oncol Clin N Am 2012; 21 (1): 1-19.

  5. Meza J, Montano A. El cáncer gástrico en México: mejoría, pero aún con mucho por hacerse. Revista de Gastroenterología de México 2016; 81 (2): 63-64. DOI: 10.1016/j. rgmx.2016.02.003

  6. Sánchez J. Tendencias de mortalidad y años potenciales de vida perdidos por cáncer gástrico en México, 2000-2012. Revista de Gastroenterología de México 2016; 81(2): 65-73. http://dx.doi.org/10.1016/j.rgmx.2016.01.002

  7. Arana J, Corona A. Cáncer gástrico. Rev Fac Med UNAM 2004; 47 (5) 204-206.

  8. Ge W, Teng B, De-Cai Y Gang C, Li-Ming Z Yi-Tao D. Dermatosis as the initial presentation of gastric cancer: two cases. Chin J Cancer Res 2014; 26 (5): 632-638. doi: 10.3978/j. issn.1000-9604.2014.10.01

  9. Martinez P, Báez J, Báez J. Signo de Leser-Trélat con carcinoma de recto. Revista de Gastroenterología de México 2014; 79 (4): 217-304. DOI: 10.1016/j.rgmx.2014.05.002

  10. Ramos S, Carvalho J, Carneiro S. Cutaneous paraneoplasia. Clin Dermatol 2011; 29 (5): 541-547. doi: 10.1016/j. clindermatol.2010.09.022

  11. Savitha S, Sacchidanand S, Dowda S. Misnomers in Dermatology: An Update. Indian J of Dermatol 2013; 58 (6): 467-474. DOI: 10.4103/0019-5154.119962

  12. Aditi R, Aarathi R, Pradeep R, Hemalatha L, Akshatha C, Amar K. HER2 expression in gastric adenocarcinoma-a study in a tertiary care centre in South India. Indian J Surg Oncol 2015; 7 (1): 18-24. doi: 10.1007/s13193- 015-0436-6

  13. Kumar R, Pitea TC. A novel endoscopic technique to diagnose gastric cancer in excluded stomach after roux-en-Y gastric bypass. ACG Case Rep J 2017; 4: e36. doi: 10.14309/ crj.2017.36

  14. Cortez M. Factores de riesgo y manejo del cáncer gástrico en pacientes ingresados al Servicio de Cirugía del Hospital Alemán Nicaragüense, Managua, durante noviembre de 2014 a noviembre de 2016. Universidad Nacional Autónoma de Nicaragua 2017; 1(1) 1-49.

  15. Pilco J, Stein J. Adenocarcinoma de la unión esófagogástrica. Revista Gastroenterol Perú 2017; 26 (2): 2-5.

  16. American Cancer Society. Surgery for Stomach Cancer. Georgia USA: American cancer society; 2017 Disponible en: https://www.cancer.org/cancer/stomach-cancer/treating/ types-of-surgery.html

  17. American cancer society. Stomach Cancer Survival Rates. Georgia USA: American cancer society; 2017 Disponible en: https://www.cancer.org/cancer/stomach-cancer/ detection-diagnosis-staging/survival-rates.html

  18. Alapatt G, Sukumar, D, Bhat R. A clinicopathological and dermoscopic correlation of seborrheic keratosis. Indian J Dermatol 2016; 61 (6): 662-627. doi: 10.4103/0019- 5154.193667

  19. Gönül M, Cevirgen B, Ozge H, Havva A. New described dermatological disorders. BioMed Res Int 2014; 616973: 1-13. https://doi.org/10.1155/2014/616973

  20. Cheng-Yu H, Chen-Wang C, Gon-Shen C, Wei-Cheng L, Cheng-Hsin C. The Leser-Trelat sign in an elderly with gastric adenocarcinoma. Int J Gerontol 2017; 11 (2): 125-126.

  21. Vora R, Kota R, Diwan N, Jivani N, Gandhi S. Skin: A mirror of internal malignancy. Indian J Med Paediatr Oncol 2016; 37 (4): 214-222. doi: 10.4103/0971-5851.195730

  22. Eastman K, Knezevich S, Raugi G. Eruptive seborrheic keratoses associated with adalimumab use. J Dermatol Case Rep 2013; 7 (2): 60-63. doi: 10.3315/ jdcr.2013.1139

  23. Da Silva J, Mesquita K, Machado Ana, Rodrigues I, Ferreira A, Maximiano S, Caravalho I, Tenfuss I. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol 2013; 88 (1): 9-22. doi: 10.1590/S0365- 05962013000100001

  24. Thomas VD, Snavely NR, Lee KK, et al. Benign epithelial tumors, hamartomas and hiperplasias. In Fitzpatrick’s: Dermatology in General Medicine. 8th ed. New York: McGraw-Hill, 2012: 1319-23.




2020     |     www.medigraphic.com